Home / Inspections / 1003362

FDA Inspection 1003362 — Genzyme Corporation

Genzyme Corporation — FEI 1220423

The FDA completed an inspection of Genzyme Corporation on February 2, 2017 in Framingham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 2, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Framingham, MA (United States)

Facility

Other inspections at this facility

  • 1294652 (VAI Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232210 (OAI Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1176107 (VAI Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904958 (VAI Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897241 (VAI Thu Sep 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources